Results 241 to 250 of about 790,941 (303)

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick   +6 more
wiley   +1 more source

Dynamic power management based on Model Predictive Control and PSO for hybrid microgrid. [PDF]

open access: yesSci Rep
Veni SV   +5 more
europepmc   +1 more source

Experimental analysis of elevated temperature and soiling loss on the rooftop PV modules performance under composite climatic conditions. [PDF]

open access: yesSci Rep
Yadav D   +8 more
europepmc   +1 more source

Regional coordination can alleviate the cost burden of a low-carbon electricity system. [PDF]

open access: yesNat Commun
Wessel J   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy